Publication | Open Access
Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With <i>RAS</i> Wild-type, Left-Sided Metastatic Colorectal Cancer
222
Citations
35
References
2023
Year
ClinicalTrials.gov Identifier: NCT02394795.
| Year | Citations | |
|---|---|---|
Page 1
Page 1